Vaishali Sanchorawala (V Sanchorawala)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 72

Top Topics

Stem Cell Transplantation

Patients Undergoing

Top Venues

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

American journal of hematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward Robert Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. Blood advances 8 (13) (2024)
Andrew Staron, Lisa M Mendelson, Tracy Joshi, Natasha J Burke, Vaishali Sanchorawala
Factors impeding organ recovery despite a deep haematological response in patients with systemic AL amyloidosis. British journal of haematology (2024)
Eli Muchtar, Morie A Gertz, Raphael Mwangi, Hamza Hassan, Angela Dispenzieri, Nelson R Leung, Francis K Buadi, David Dingli, Andrew Staron, Vaishali Sanchorawala
Long-term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system. American journal of hematology (2024)
Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward Robert Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. Blood advances 8 (13) (2024)
Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward Robert Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. Blood advances 8 (13) (2024)
Rajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, Divaya Bhutani, Morie A Gertz, Angela Dispenzieri, Shaji K Kumar, Anita D'Souza, Anannya Patwari, Andrew J Cowan, Gui Zhen Chen, Paolo Milani, Giovanni Palladini, Vaishali Sanchorawala, Geethika Bodanapu, Stefan Schönland, Suzanne Lentzsch, Eli Muchtar
Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy. Blood (2024)
Shankara K Anand, Andrew Staron, Lisa M Mendelson, Tracy Joshi, Natasha Burke, Vaishali Sanchorawala, Ashish Verma
Machine-learning based subgroups of AL amyloidosis and cumulative incidence of mortality and end stage kidney disease. American journal of hematology (2024)
Vaishali Sanchorawala
Systemic Light Chain Amyloidosis. The New England journal of medicine 390 (24) (2024)
Ramya Ramachandran, Darshi Shah, Catherine Luo, Veer Shah, Edward Robert Scheffer Cliff, Vaishali Sanchorawala, Suzanne Lentzsch, Rajshekhar Chakraborty
The Clinical Trials Landscape in Immunoglobulin Light Chain Amyloidosis: A Systematic Review. Blood advances (2024)
Vaishali Sanchorawala
Systemic Light Chain Amyloidosis. The New England journal of medicine 390 (24) (2024)
Vaishali Sanchorawala, Bruna Barroso, Anthony C Shelton, Elise Goetz, Lisa Mendelson, Tracy Joshi, Natasha J Burke, J Mark Sloan, Andrew Staron
Defying the Odds: 30 Years in AL Amyloidosis Research, Recent Barriers to Clinical Trial Enrollment. Blood advances (2024)
Karina Preeti Verma, Simon Gilroy, David Mueller, Julie Li, Vaishali Sanchorawala, Andrew Staron
Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report. Diagnostic pathology 18 (1) (2023)
Joshua N Gustine, Andrew Staron, Lisa Mendelson, Tracy Joshi, Deepa M Gopal, Frederick L Ruberg, Omar K Siddiqi, Vaishali Sanchorawala
Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis. Blood advances (2023)
Adebanke L Adebayo, Katherine E Rowan, Vaishali Sanchorawala, Mackenzie N Boedicker, Deborah D Boedicker
Evaluating the Amyloidosis Speakers Bureau: the influence of amyloidosis patients' narratives on medical students' knowledge, attitudes, and behavioral intent. MedEdPublish (2016) 13 (2023)
K H Vincent Lau, Tatiana Prokaeva, Luke Zheng, Gheorghe Doros, Michelle C Kaku, Brian Spencer, John Berk, Vaishali Sanchorawala
Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2023)
Vaishali Sanchorawala, Ashutosh D Wechalekar, Kihyun Kim, Stefan O Schönland, Heather J Landau, Fiona Kwok, Kenshi Suzuki, Angela Dispenzieri, Giampaolo Merlini, Raymond L Comenzo, Dasha Cherepanov, Vanessa C Hayden, Arun Kumar, Richard Labotka, Douglas V Faller, Efstathios Kastritis
Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice. American journal of hematology (2023)
Karina Preeti Verma, Simon Gilroy, David Mueller, Julie Li, Vaishali Sanchorawala, Andrew Staron
Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report. Diagnostic pathology 18 (1) (2023)
Karina Preeti Verma, Simon Gilroy, David Mueller, Julie Li, Vaishali Sanchorawala, Andrew Staron
Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report. Diagnostic pathology 18 (1) (2023)
Avery A Rizio, Michelle K White, Anita D'Souza, Kristen Hsu, Paula Schmitt, Tiffany P Quock, James Signorovitch, Isabelle Lousada, Vaishali Sanchorawala
Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group. Patient related outcome measures 14 (2023)
Vaishali Sanchorawala, Ashutosh D Wechalekar, Kihyun Kim, Stefan O Schönland, Heather J Landau, Fiona Kwok, Kenshi Suzuki, Angela Dispenzieri, Giampaolo Merlini, Raymond L Comenzo, Dasha Cherepanov, Vanessa C Hayden, Arun Kumar, Richard Labotka, Douglas V Faller, Efstathios Kastritis
Quality of Life and Symptoms Among Patients With Relapsed/Refractory AL Amyloidosis Treated With Ixazomib-Dexamethasone Versus Physician's Choice. American journal of hematology (2023)
Andrew Staron, Lisa M Mendelson, Tracy Joshi, Frederick L Ruberg, Vaishali Sanchorawala
Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2023)
Morie A Gertz, Adam David Cohen, Raymond L Comenzo, Efstathios Kastritis, Heather J Landau, Edward N Libby, Michaela Liedtke, Vaishali Sanchorawala, Stefan Schönland, Ashutosh D Wechalekar, Jeffrey A Zonder, Giovanni Palladini, Jackie Walling, Spencer Guthrie, Christie Nie, Carol Karp, Yuying Jin, Gene G Kinney, Giampaolo Merlini
Birtamimab plus standard of care in light chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood (2023)
Lisa Mendelson, Tatiana Prokaeva, K H Vincent Lau, Vaishali Sanchorawala, Kristen McCausland, Brian Spencer, Surendra Dasari, Ellen D McPhail, Michelle C Kaku
Hereditary gelsolin amyloidosis: a rare cause of cranial, peripheral and autonomic neuropathies linked to D187N and Y447H substitutions. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2023)
Vaishali Sanchorawala
Eureka Moment-Innovation Comes of an Age in Light Chain Amyloidosis. JCO oncology practice (2023)
Vaishali Sanchorawala, Giovanni Palladini, Monique C Minnema, Arnaud Jaccard, Hans C Lee, Simon Gibbs, Peter Mollee, Christopher P Venner, Jin Lu, Stefan Schönland, Moshe E E Gatt, Kenshi Suzuki, Kihyun Kim, María Teresa Cibeira, Meral Beksac, Edward Libby, Jason Valent, Vania Tietsche de Moraes Hungria, Sandy W Wong, Michael Rosenzweig, Naresh Bumma, Dominique Chauveau, Katharine S Gries, John Fastenau, Nam Phuong Tran, Xiang Qin, Sandra Y Vasey, Brendan M Weiss, Jessica Vermeulen, Kai Fai Ho, Giampaolo Merlini, Raymond L Comenzo, Efstathios Kastritis, Ashutosh D Wechalekar
Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study. American journal of hematology 97 (6) (2022)
Andrew Staron, Luke Zheng, Gheorghe Doros, Vaishali Sanchorawala
Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans. Blood cancer journal 12 (7) (2022)
Ashutosh D Wechalekar, Vaishali Sanchorawala
Daratumumab in AL amyloidosis. Blood 140 (22) (2022)
Andrea Havasi, Cihan Heybeli, Nelson Leung, Avital Angel-Korman, Vaishali Sanchorawala, Oliver Cohen, Ashutosh D Wechalekar, Frank Bridoux, Insara Jaffer, Victoria Gutgarts, Hani Hassoun, Maya Levinson, Cara Rosenbaum, Paolo Milani, Giovanni Palladini, Giampaolo Merlini, Ute Hegenbart, Stefan O Schönland, Kaya Veelken, Alexander Pogrebinsky, Gheorghe Doros, Heather J Landau
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group. Blood cancer journal 12 (8) (2022)
Michelle C Kaku, Shivkumar Bhadola, John L Berk, Vaishali Sanchorawala, Lawreen H Connors, K H Vincent Lau
Neurological manifestations of hereditary transthyretin amyloidosis: a focus on diagnostic delays. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 29 (3) (2022)
Joshua N Gustine, Andrew Staron, Raphael E Szalat, Lisa M Mendelson, Tracy Joshi, Frederick L Ruberg, Omar Siddiqi, Deepa M Gopal, Camille Vanessa Edwards, Andrea Havasi, Michelle C Kaku, K H Vincent Lau, John L Berk, John Mark Sloan, Vaishali Sanchorawala
Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. American journal of hematology 97 (9) (2022)
Ashutosh D Wechalekar, Maria Teresa Cibeira, Simon D Gibbs, Arnaud Jaccard, Shaji K Kumar, Giampaolo Merlini, Giovanni Palladini, Vaishali Sanchorawala, Stefan O Schönland, Christopher Venner, Mario Boccadoro, Efstathios Kastritis
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)
Andrew Staron, Karina Preeti Verma, Vaishali Sanchorawala
Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis. British journal of haematology 198 (5) (2022)
Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan O Schönland, Kaya Veelken, Ute Hegenbart, Susan M Geyer, Shaji K Kumar, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzch, Alexander Coltoff, Joan Bladé, Maria Teresa Cibeira, Oliver Cohen, Darren Foard, Ashutosh Wechalekar, Morie A Gertz
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Tatiana Prokaeva, Tracy Joshi, Elena S Klimtchuk, Victoria M Gibson, Brian Spencer, Omar Siddiqi, Dobrin Nedelkov, Yueming Hu, John L Berk, Sarah A M Cuddy, Surendra Dasari, April Chiu, Lauren A Choate, Ellen Darcy McPhail, Haili Cui, Hui Chen, Eric J Burks, Vaishali Sanchorawala, Lawreen H Connors
A novel substitution of proline (P32L) destabilises β2-microglobulin inducing hereditary systemic amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)
Vaishali Sanchorawala, Mario Boccadoro, Morie A Gertz, Ute Hegenbart, Efstathios Kastritis, Heather J Landau, Peter Mollee, Ashutosh Wechalekar, Giovanni Palladini
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2021)
Shayna R Sarosiek, Cindy Varga, Allison Jacob, Maria Teresa Fulciniti, Nikhil C Munshi, Vaishali Sanchorawala
Detection of minimal residual disease by next generation sequencing in AL amyloidosis. Blood cancer journal 11 (6) (2021)
Andrew Staron, Luke Zheng, Gheorghe Doros, Lawreen H Connors, Lisa M Mendelson, Tracy Joshi, Vaishali Sanchorawala
Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood cancer journal 11 (8) (2021)
Angela Dispenzieri, Efstathios Kastritis, Ashutosh D Wechalekar, Stefan O Schönland, Kihyun Kim, Vaishali Sanchorawala, Heather J Landau, Fiona Kwok, Kenshi Suzuki, Raymond L Comenzo, Deborah Berg, Guohui Liu, Arun Kumar, Douglas V Faller, Giampaolo Merlini
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis. Leukemia (2021)
Vanessa Fiorini Furtado, Dina Brauneis, Janice Weinberg, Noon Elhassan, John Mark Sloan, Vaishali Sanchorawala
Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis. Bone marrow transplantation (2021)
Raphael E Szalat, Joshua Gustine, J Mark Sloan, Camille V Edwards, Vaishali Sanchorawala
Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab. American journal of hematology (2021)
Vikram J Premkumar, Suzanne Lentzch, Samuel Pan, Divaya Bhutani, Joshua Richter, Sundar Jagannath, Michaela Liedtke, Arnaud Jaccard, Ashutosh D Wechalekar, Raymond Comenzo, Vaishali Sanchorawala, Bruno Royer, Michael Rosenzweig, Jason Valent, Stefan O Schönland, Rafael Fonseca, Sandy Wong, Prashant Kapoor
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood cancer journal 11 (1) (2021)
Vaishali Sanchorawala
Delay treatment of AL amyloidosis at relapse until symptomatic: devil is in the details. Blood advances 3 (2) (2020)
Amanda Schulman, Lawreen H Connors, Janice Weinberg, Lisa M Mendelson, Tracy Joshi, Anthony C Shelton, Vaishali Sanchorawala
Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis. European journal of haematology 105 (4) (2020)
Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, Monique Minnema, Murielle Roussel, Arnaud Jaccard, Ute Hegenbart, Shaji K Kumar, Maria T Cibeira, Joan Blade, Meletios- Athanasios Dimopoulos
Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic. British journal of haematology 190 (3) (2020)
Shayna Sarosiek, Luke Zheng, J Mark Sloan, Karen Quillen, Dina Brauneis, Vaishali Sanchorawala
Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis. Blood cancer journal 10 (8) (2020)
Andrew Staron, Lawreen H Connors, Luke Zheng, Gheorghe Doros, Vaishali Sanchorawala
Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities. Blood cancer journal 10 (11) (2020)
Brett Dumas, Hassan Yameen, Shayna R Sarosiek, John Mark Sloan, Vaishali Sanchorawala
Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 27 (4) (2020)
Raphael Szalat, Shayna R Sarosiek, Andrea Havasi, Dina Brauneis, John Mark Sloan, Vaishali Sanchorawala
Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis. Leukemia 35 (3) (2020)
Michael Dennis, Asaf Maoz, David Hughes, Vaishali Sanchorawala, J Mark Sloan, Shayna R Sarosiek
Bortezomib ocular toxicities: Outcomes with ketotifen. American journal of hematology 94 (3) (2019)
Pooja Phull, Vaishali Sanchorawala, Dina Brauneis, John Mark Sloan, Omar K Siddiqi, Karen Quillen, Shayna R Sarosiek
High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone marrow transplantation 54 (8) (2019)
Anita Pudusseri, Vaishali Sanchorawala, J Mark Sloan, Katherine M Bever, Gheorghe Doros, Shivangi Kataria, Shayna R Sarosiek
Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis. American journal of hematology 94 (10) (2019)
David A Qualls, Gregory D Lewis, Vaishali Sanchorawala, Andrew Staron
Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 19 (11) (2019)
Vishal K Gupta, Paul S White, Dina Brauneis, Anthony C Shelton, Karen Quillen, Vaishali Sanchorawala, Shayna R Sarosiek, John Mark Sloan
Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. American journal of hematology 94 (12) (2019)
Vaishali Sanchorawala, Gheorghe Doros, Anthony C Shelton
Long term outcome of patients treated on clinical trials of immunomodulatory agents for the treatment of Immunoglobulin light chain (AL) amyloidosis: A pooled analysis. American journal of hematology 94 (7) (2019)
Andrew Staron, Lawreen H Connors, Frederick L Ruberg, Lisa M Mendelson, Vaishali Sanchorawala
A new era of amyloidosis: the trends at a major US referral centre. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 26 (4) (2019)
Avital Angel-Korman, Aala Jaberi, Vaishali Sanchorawala, Andrea Havasi
The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 27 (1) (2019)
Brian Lilleness, Gheorghe Doros, Frederick L Ruberg, Vaishali Sanchorawala
Establishment of brain natriuretic peptide - based criteria for evaluating cardiac response to treatment in light chain (AL) amyloidosis. British journal of haematology 188 (3) (2019)
Andrew Staron, Yachana Kataria, David L Murray, John Mark Sloan, Vaishali Sanchorawala
Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes. American journal of hematology 95 (2) (2019)
Shayna R Sarosiek, Vaishali Sanchorawala
Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives. Journal of blood medicine 10 (2019)
Kristen L McCausland, Tiffany P Quock, Avery A Rizio, Martha S Bayliss, Michelle K White, Spencer D Guthrie, Vaishali Sanchorawala
Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis. British journal of haematology 185 (5) (2018)
Paul S White, Pooja Phull, Dina Brauneis, John Mark Sloan, Karen Quillen, Shayna Sarosiek, Vaishali Sanchorawala
High-dose melphalan and stem cell transplantation in AL amyloidosis with elevated cardiac biomarkers. Bone marrow transplantation 53 (12) (2018)
Pooja Phull, Vaishali Sanchorawala, Lawreen H Connors, Gheorghe Doros, Frederick L Ruberg, John L Berk, Shayna R Sarosiek
Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (1) (2018)
Andrea Havasi, Gheorghe Doros, Vaishali Sanchorawala
Predictive value of the new renal response criteria in AL amyloidosis treated with high dose melphalan and stem cell transplantation. American journal of hematology 93 (5) (2018)
Tulip Jhaveri, Shayna Sarosiek, Frederick L Ruberg, Omar Siddiqi, John L Berk, Vaishali Sanchorawala
Once AL amyloidosis: not always AL amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (2) (2018)
Parameswaran Hari, Huamao Mark Lin, Carl V Asche, Jinma Ren, Candice Yong, Katarina Luptakova, Douglas V Faller, Vaishali Sanchorawala
Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (1) (2018)
Vina P Nguyen, Allison Rosenberg, Lisa M Mendelson, Raymond L Comenzo, Cindy Varga, Vaishali Sanchorawala
Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (3) (2018)
Richard M Giadone, Jessica D Rosarda, Prithvi Reddy Akepati, Arianne C Thomas, Batbold Boldbaatar, Marianne F James, Andrew A Wilson, Vaishali Sanchorawala, Lawreen H Connors, John L Berk, R Luke Wiseman, George J Murphy
A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (3) (2018)
Brian Lilleness, Frederick L Ruberg, Roberta Mussinelli, Gheorghe Doros, Vaishali Sanchorawala
Development and validation of a survival staging system incorporating BNP in patients with light chain amyloidosis. Blood 133 (3) (2018)
Shayna R Sarosiek, Karen Quillen, John Mark Sloan, Dina Brauneis, Vaishali Sanchorawala
Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation. Blood 132 (7) (2018)
Sabrina L Browning, Karen Quillen, John Mark Sloan, Gheorghe Doros, Shayna R Sarosiek, Vaishali Sanchorawala
Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation. Blood 130 (11) (2017)
V P Nguyen, D Brauneis, M Kaku, John Mark Sloan, S Sarosiek, K Quillen, A C Shelton, Vaishali Sanchorawala
Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis. Bone marrow transplantation 53 (3) (2017)
Vaishali Sanchorawala, Anthony C Shelton, Stephen Lo, Cindy Varga, John Mark Sloan, David C Seldin
Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial. Blood 128 (8) (2016)
Vaishali Sanchorawala, Fangui Sun, Karen Quillen, John Mark Sloan, John L Berk, David C Seldin
Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience. Blood 126 (20) (2015)